Gossamer Bio Inc (GOSS)
0.8253
0.00 (0.00%)
USD |
NASDAQ |
Apr 17, 16:00
0.8253
0.00 (0.00%)
After-Hours: 20:00
Gossamer Bio Max Drawdown (5Y): 98.21% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| March 31, 2024 | 98.21% |
| February 29, 2024 | 98.21% |
| January 31, 2024 | 98.21% |
| December 31, 2023 | 98.21% |
| November 30, 2023 | 98.21% |
| October 31, 2023 | 98.21% |
| September 30, 2023 | 97.10% |
| August 31, 2023 | 96.41% |
| July 31, 2023 | 96.41% |
| June 30, 2023 | 96.41% |
| May 31, 2023 | 96.41% |
| April 30, 2023 | 96.41% |
| March 31, 2023 | 96.41% |
| February 28, 2023 | 93.54% |
| January 31, 2023 | 93.50% |
| December 31, 2022 | 93.50% |
| November 30, 2022 | 77.72% |
| October 31, 2022 | 77.72% |
| September 30, 2022 | 77.72% |
| August 31, 2022 | 77.72% |
| July 31, 2022 | 77.72% |
| June 30, 2022 | 77.72% |
| May 31, 2022 | 76.07% |
| April 30, 2022 | 74.21% |
| March 31, 2022 | 72.94% |
| Date | Value |
|---|---|
| February 28, 2022 | 72.94% |
| January 31, 2022 | 72.94% |
| December 31, 2021 | 72.94% |
| November 30, 2021 | 72.94% |
| October 31, 2021 | 72.94% |
| September 30, 2021 | 72.94% |
| August 31, 2021 | 72.94% |
| July 31, 2021 | 72.94% |
| June 30, 2021 | 70.14% |
| May 31, 2021 | 70.14% |
| April 30, 2021 | 70.14% |
| March 31, 2021 | 70.14% |
| February 28, 2021 | 70.14% |
| January 31, 2021 | 70.14% |
| December 31, 2020 | 70.14% |
| November 30, 2020 | 70.14% |
| October 31, 2020 | 70.14% |
| September 30, 2020 | 70.14% |
| August 31, 2020 | 70.14% |
| July 31, 2020 | 70.14% |
| June 30, 2020 | 70.14% |
| May 31, 2020 | 70.14% |
| April 30, 2020 | 70.14% |
| March 31, 2020 | 70.14% |
| February 29, 2020 | 51.33% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
32.75%
Minimum
Apr 2019
98.21%
Maximum
Oct 2023
72.66%
Average
72.94%
Median
Jul 2021
Max Drawdown (5Y) Benchmarks
| Amicus Therapeutics Inc | 74.97% |
| TG Therapeutics Inc | 93.19% |
| Replimune Group Inc | 87.18% |
| 89bio Inc | -- |
| Moderna Inc | 85.65% |